| 1 |
向旭,朱妍,朱海杭. 糖尿病与胃食管反流病临床流行病学研究 [J].胃肠病学和肝病学杂志,2014, 23(3):292-295.
|
| 2 |
Siavash M, Tabbakhian M, Sabzghabaee AM, et a1. Severity of gastrointestinal side effects of metformin tablet compared to met-formin capsule in type 2 diabetes mellitus patients [J]. J Res Pharm Pract,2017, 6(2):73-76.
|
| 3 |
皮尔地瓦斯·麦麦提玉素甫, 艾克拜尔·艾力, 买买提·依斯热依力,等. 减重手术类型与胃食管反流病发病相关性的研究进展[J/OL]. 中华胃食管反流病电子杂志, 2019, 6(3): 161-165.
|
| 4 |
Sawada A, Hashimoto A, Uemura R, et al. Effect of EP1 receptor antagonist on transient lower esophageal sphincter relaxations in humans [J]. Digestion, 2020, 101(3):270-278.
|
| 5 |
魏从光, 魏晓艳, 郝润春. 胃食管反流病的临床研究进展 [J]. 武警医学, 2020, 31(6):88-91.
|
| 6 |
汤浩,丁海蛟. 胃食管反流病发病因素研究 [J].临床军医杂志,2020, 48(6):746-747.
|
| 7 |
Natalini J, Palit A, Sankineni A, et al. Diabetes mellitus is an independent risk for gastroesophageal reflux disease among urban African Americans [J]. Dis Esophagus, 2015, 28(5):405-11.
|
| 8 |
Maev IV, Iurenev GL, Kakhramanova DA. Peculiarities of gastroesophageal reflux disease in patients with type 2 diabetes mellitus [J]. Klinicheskaia Meditsina, 2012, 90(9):53-56.
|
| 9 |
Sirchak YS, Stan MP, Brych VV. Changes in cholecystokinin level in patients with gastroesophageal reflux disease on the background of type II diabetes [J]. Wiad Lek, 2018,71(2 pt 1):333-336.
|
| 10 |
Kellerman R, Kintanar T. Gastroesophageal reflux disease [J]. Prim Care, 2017, 44(4):561-573.
|
| 11 |
Ribolsi M, Balestrieri P, Holloway RH, et al. Intra-bolus pressure and esophago gastric gradient, assessed with high-resolution manometry, are associated with acid exposure and proximal migration of refluxate [J]. Dis Esophagus, 2016, 29(8): 1020-1026.
|
| 12 |
Menezes MA, Herbella FAM. Pathophysiology of gastroesophageal reflux disease [J]. World J Surg, 2017, 41(7):1666-1671.
|
| 13 |
Bou Daher H, Sharara AI. Gastroesophageal reflux disease, obesity and laparoscopic sleeve gastrectomy: the burning questions [J]. World J Gastroenterol, 2019, 25(33): 4805-4813.
|
| 14 |
宋进展, 徐光耀, 周海燕,等. 2型糖尿病患者幽门螺旋杆菌感染情况及胃肠病变特点 [J]. 临床医学研究与实践, 2019, 4(14):52-54.
|
| 15 |
Gyawali CP, Fass R. Management of gastroesophageal reflux Disease [J]. Gastroenterology, 2018, 154(2):302-318.
|
| 16 |
Brandt SJ, Götz A, Tschöp MH, Müller TD. Gut hormone polyagonists for the treatment of type 2 diabetes [J]. Peptides, 2018, 100:190-201
|
| 17 |
张亚萍, 高革, 张宽学,等. 糖尿病胃肠功能紊乱模型胃肠道超微结构变化的研究 [J]. 临床消化病杂志, 2002(4):150-152.
|
| 18 |
伊尔潘江·库尔班, 买买提·依斯热依力, 艾克拜尔·艾力. 肥胖患者腹腔镜袖状胃切除术后并发症的防治研究进展 [J]. 中国医师杂志, 2020, 22(9):1431-1434.
|
| 19 |
Savarino E, de Bortoli N, De Cassan C, et al. The natural history of gastro-esophageal reflux disease: a comprehensive review [J]. Dis Esophagus, 2017, 30(2):1-9.
|
| 20 |
KoichiMuroi, RyojiMiyahara, KoheiFunasaka, et al. Comparison of High-Resolution Manometry in Patients Complaining of Dysphagia among Patients with or without Diabetes Mellitus [J]. Digestion, 2021, 102: 554-562.
|
| 21 |
Monreal-Robles R, Remes-Troche JM. Diabetes and the Esophagus [J]. Curr Treat Options Gastroenterol, 2017, 15(4):475-489.
|
| 22 |
Gokturk S, Akyuz F, Arici S, et al. Gastroesophageal reflux in asymptomatic patients with diabetes: an impedance study diabetes, obesity and gastroesophageal reflux [J]. Exp Clin Endocrinol Diabetes, 2020, 128(1):52-58.
|
| 23 |
乙兵,种新力. 糖尿病大鼠胃肠功能障碍与胃动素、胆囊收缩素、生长激素相关性研究 [J].疾病监测与控制, 2014, 8(12):779-780.
|
| 24 |
Freeman R. Diabetic autonomic neuropathy [J]. Handb Clin Neurol, 2014, 126: 63-79.
|
| 25 |
Liu L, Li S, Zhu K, et al. Relationship between esophageal motility and severity of gastroesophageal reflux disease according to the Los Angeles classification [J]. Medicine (Baltimore), 2019, 98(19):e15543.
|
| 26 |
向旭. 糖尿病与胃食管反流病的相关性研究[D].中南大学, 2014.
|
| 27 |
蔡华容. 糖尿病胃肠道并发症相关研究 [J]. 2018, 13(23):195-196
|
| 28 |
Li YW, Xie CX, Wu KM, et al. Motility characteristics in the transition zone in gastroesophageal reflux disease (GORD) patients [J]. BMC Gastroenterol, 2016, 16(1):106.
|
| 29 |
Deng Y, Pan L, Qian W. Associations between the severity of reflux esophagitis in children and changes in oxidative stress, serum inflammation, vasoactive intestinal peptide and motilin [J]. Exp Ther Med, 2019, 18(5):3509-3513.
|
| 30 |
赵新胜, 买买提·依斯热依力, 克力木·阿不都热依木. 非糜烂性食管炎和内脏高敏感研究新进展[J/OL]. 中华胃食管反流病电子杂志, 2019, 6(4): 211-215.
|
| 31 |
Iwasaki M, Akiba Y, Kaunitz JD. Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system [J]. F1000Res,2019, 8:F1000 Faculty Rev-1629.
|
| 32 |
向旭, 朱海杭. 糖尿病并发胃食管反流病患者血浆P物质和血管活性肠肽的水平及意义 [J]. 国际消化病杂志, 2014, 34(4):267-270.
|
| 33 |
Clarrett DM, Hachem C. Gastroesophageal reflux disease (GERD) [J]. Mo Med, 2018, 115(3):214-218.
|
| 34 |
Martin AM, Sun EW, Keating DJ. Mechanisms controlling hormone secretion in human gut and its relevance to metabolism [J]. J Endocrinol, 2019, 244(1):R1-R15.
|
| 35 |
伊力亚尔·麦麦提江, 克力木·阿不都热依木. 胃食管反流病与胰岛素抵抗的研究进展[J/OL]. 中华胃食管反流病电子杂志, 2019, 6(2):106-109.
|
| 36 |
Geysen H, Gielis E, Deloose E, et al. Acute administration of fructans increases the number of transient lower esophageal sphincter relaxations in healthy volunteers [J]. Neurogastroenterol Motil, 2020, 32(1):e13727.
|
| 37 |
Kethman W, Hawn M. New approaches to gastroesophageal reflux disease [J]. J Gastrointest Surg, 2017, 21(9):1544-1552.
|
| 38 |
Chen J, Brady P. Gastroesophageal reflux disease: pathophysiology, diagnosis, and treatment [J]. Gastroenterol Nurs, 2019, 42(1):20-28.
|
| 39 |
Ha JO, Lee TH, Lee CW, et al. Prevalence and risk factors of gastroesopha geal reflux disease in patients with type 2 diabetes mellitus [J]. Diabetes Metab J, 2016, 40(4): 297-307.
|